RELAPSED NEUROBLASTOMA
Clinical trials for RELAPSED NEUROBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED NEUROBLASTOMA trials appear
Sign up with your email to follow new studies for RELAPSED NEUROBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kids with Tough-to-Treat childhood cancer
Disease control Recruiting nowThis trial is testing new combinations of cancer drugs for children and young adults whose neuroblastoma has come back after initial treatment. The study will compare different drug regimens to see which ones are safest and most effective at controlling the cancer and improving s…
Matched conditions: RELAPSED NEUROBLASTOMA
Phase: PHASE1, PHASE2 • Sponsor: University of Birmingham • Aim: Disease control
Last updated Apr 04, 2026 00:20 UTC
-
New immune cell therapy tested for tough childhood cancer
Disease control Recruiting nowThis early-stage trial is testing a new type of treatment called CAR T-cell therapy for children and young adults with neuroblastoma that has come back or hasn't responded to standard treatments. Doctors take a patient's own immune cells, modify them in a lab to better target the…
Matched conditions: RELAPSED NEUROBLASTOMA
Phase: PHASE1, PHASE2 • Sponsor: Roberto Chiarle • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New hope for kids with tough cancers: first test of 'Living Drug' therapy
Disease control Recruiting nowThis is the first time researchers are testing a new type of cell therapy called GPC2 CAR T in children. The trial aims to find a safe dose for kids with advanced neuroblastoma or metastatic retinoblastoma that has come back or hasn't responded to all other standard treatments. D…
Matched conditions: RELAPSED NEUROBLASTOMA
Phase: PHASE1 • Sponsor: Stephan Grupp MD PhD • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New hope for kids with tough cancers: first test of donor cell therapy
Disease control Recruiting nowThis is a first-in-human safety study testing a new type of donor immune cell therapy for children whose neuroblastoma or osteosarcoma has come back or hasn't responded to standard treatments. The main goal is to find the safest dose of these cells when given alongside a combinat…
Matched conditions: RELAPSED NEUROBLASTOMA
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New hope for kids with incurable cancer: first trial of groundbreaking cell therapy begins
Disease control Recruiting nowThis is the first-ever study in people to test a new type of CAR-T cell therapy called PHOX2B PC-CAR T for children with advanced, high-risk neuroblastoma that has come back or not responded to other treatments. The main goal is to find a safe dose and see if the treatment can be…
Matched conditions: RELAPSED NEUROBLASTOMA
Phase: PHASE1 • Sponsor: Stephan Grupp MD PhD • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC